#JournalWatch@journal_CHEST
More data for peripheral vasopressors! This study found that peripheral pressors offered a practical advantage and faster administration but wide practice pattern variation.
#critPRN
https://t.co/86fu4wciVg
🆕️🔥Systematic review:
NO evidence that treatment with antibiotics is associated with improved delirium outcomes in older adults with pyuria or bacteriuria and without systemic signs of infection or genitourinary symptoms #idxposts
Thanks @Inox94 https://t.co/b5ZGlNnqFz
Andexanet alfa: expensive and harmful?
There was no reason to use this drug until now, and nothing changes with the first RCT
#FOAMed
https://t.co/c5aVmhADMx
🔥Just published 🔥
CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024
#doxyPEP#IDXposts
https://t.co/TBFA8JWOVs
How long is too long to be performing CPR in patients who suffer in-hospital cardiac arrest? Every patient and situation is obviously different but it shouldn’t come as a surprise that beyond 30 minutes, things don’t look too good. 🎩 tip to the authors.
https://t.co/4Ise541cSv
we have known the rate of thrombotic events with andexanet for a long time. 10% is not unexpected based on previous studies.
ANNEXA-4 prelim analysis (2016) - 18%
ANNEXA-4 full analysis (2019) - 10%
ANNEXA-I (2024) - 10.3%
#TwitteRx#FOAMed
New manuscript from EAST multicentered (10 site) AA vs 4PCC in trauma pt's showed no diff in transfusion requirements and maybe shorter ICU LOS w/ 4PCC than AA
Decent size and like how they verified pts took a dose w/in 12 hrs of arrival
https://t.co/57qjxP5j8j
Post-hoc analysis of the ULTRA trial shows that early TXA in good grade aSAH patients leads to WORSE functional outcomes than usual care. Outcomes in poor grade with similar.
TXA is mostly harmless... but not fully harmless. Use it with care!
https://t.co/wAWCw8sHgQ
Ketamine drips for sedation can be extremely effective. We just need to sort out/standardize the dosing regimen. This paper evaluates numerous published protocols in an attempt to make sense of it all. 🎩 tip to the authors.
https://t.co/4Ise540F2X
Thank you to Madeline Ganter from our fabulous @uncrxresidency class who designed our latest #EDpharmacyeducationboard to spread the word about our new High-Dose Nitroglycerin for SCAPE guideline in the ED (adopted from UNC REX!)
Go team!
#EDRx#twitteRx#pharmacyguideline
#CPPPLU Highlights: A study in @Crit_Care found no difference in 28-day mortality with initial adequate combination antibiotic therapy vs. adequate single-drug therapy in critically ill pts with monobacterial gram negative HAP, vHAP, and VAP. #PharmICU
https://t.co/wGUTyiKmba
🆕️⚡️⚡️ @AJHPOfficial
Intravenous push antibiotics in ED decrease the time from ordering to the start of administration and result in significant cost savings compared to IV piggyback #IDXposts
https://t.co/BvBJ77MtiM
Check out the details about our upcoming PharmEMergency/AEMP conference happening in May! We want to see all types of EM pharmacists and providers join us and get involved! https://t.co/YxCcA4HZXZ @MeganARech @GilbertPharmD @LRayRx@SAEMonline @CBthePHARMD @EmergPharm
TIMELESS trial: Tenecteplase for thrombolysis in a 4.5-to-24-hour window did not improve disability outcomes at 90 days in patients with ischemic stroke who had been chosen on the basis of imaging. Most patients had endovascular thrombectomy. https://t.co/wCfSoKO79z #ISC24
GWTG Stroke study found earlier reversal treatment for brain hemorrhage patients on blood thinners led to better outcomes especially in first 60 minutes or “golden hour."
#GWTGResearch#ISC24
https://t.co/4BHpxxwSKZ